Edition:
United States

ZIOPHARM Oncology Inc (ZIOP.PH)

ZIOP.PH on Philadelphia Stock Exchange

2.50USD
17 Oct 2018
Change (% chg)

$-0.11 (-4.21%)
Prev Close
$2.61
Open
$2.47
Day's High
$2.56
Day's Low
$2.42
Volume
2,711
Avg. Vol
4,847
52-wk High
$5.81
52-wk Low
$2.25

Chart for

About

ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which is seeking to develop, acquire and commercialize, on its own or with partners, a portfolio of cancer therapies that address unmet medical needs. The Company is focused on developing products in immuno-oncology that employ gene expression, control and cell technologies... (more)

Overall

Beta: 1.41
Market Cap(Mil.): $405.78
Shares Outstanding(Mil.): 142.38
Dividend: --
Yield (%): --

Financials

  ZIOP.PH Industry Sector
P/E (TTM): -- 119.85 32.14
EPS (TTM): -0.53 -- --
ROI: -60.74 1.96 12.83
ROE: -- 1.12 14.95

BRIEF-Ziopharm Oncology Reports Q1 Loss Per Share $0.15

* ZIOPHARM ONCOLOGY REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

May 10 2018

Earnings vs. Estimates